Status and phase
Conditions
Treatments
About
This is a multi-center, open-label, Phase 1/2 study of ZG005 for the treatment of subjects with advanced solid tumors, and consists of three stages: dose escalation and confirmation of MTD/recommended dose.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
484 participants in 2 patient groups
Loading...
Central trial contact
Yongsheng Chu
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal